PetVivo Holdings, Inc. (PETV)
OTCMKTS · Delayed Price · Currency is USD
0.8070
+0.0070 (0.88%)
Aug 1, 2025, 3:38 PM EDT
Theseus Pharmaceuticals Revenue
In the fiscal year ending March 31, 2025, PetVivo Holdings had annual revenue of $1.13M with 16.91% growth. PetVivo Holdings had revenue of $224.75K in the quarter ending March 31, 2025, with 365.65% growth.
Revenue
1.13M
Revenue Growth
+16.91%
P/S Ratio
19.62
Revenue / Employee
47.19K
Employees
24
Market Cap
22.22M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.13M | 163.83K | 16.91% |
| Mar 31, 2024 | 968.71K | 51.54K | 5.62% |
| Mar 31, 2023 | 917.16K | 801.58K | 693.49% |
| Mar 31, 2022 | 115.59K | 103.01K | 818.95% |
| Mar 31, 2021 | 12.58K | 8.99K | 250.56% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo, Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 84.04M |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.70M |
PetVivo Holdings News
- 3 days ago - PetVivo Holdings Inc. to Trade on OTCQX Best Market - GlobeNewsWire
- 4 weeks ago - PetVivo Holdings, Inc. (PETV) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - PetVivo Holdings GAAP EPS of -$0.39, revenue of $1.1M - Seeking Alpha
- 4 weeks ago - PetVivo Reports Fiscal 2025 Results - GlobeNewsWire
- 5 weeks ago - PetVivo Sets Fiscal Fourth Quarter 2025 Conference Call for Monday, June 30 at 5:00 p.m. ET - GlobeNewsWire
- 5 weeks ago - PETVIVO HOLDINGS, INC. ANNOUNCES CLOSE OF PURCHASE OPTION TIED TO SERIES B CONVERTIBLE PREFERRED STOCK OFFERING - GlobeNewsWire
- 6 weeks ago - PETVIVO HOLDINGS, INC. ANNOUNCES INVESTOR EXERCISE OF PURCHASE OPTION TIED TO SERIES B CONVERTIBLE PREFERRED STOCK OFFERING - GlobeNewsWire
- 2 months ago - PetVivo and Commonwealth Partner to Advance Equine Wellness Across Thoroughbred Racing - GlobeNewsWire